Association of mitochondrial displacement loop polymorphisms with diarrhea-predominant irritable bowel syndrome: A preliminary study

被引:4
|
作者
Liu, Zi Yu [1 ]
Gua, Xia Xu [1 ]
Zhang, Rong Gui [1 ]
Wang, Xiao Xiao [1 ]
Ai, Jie [1 ]
Wang, Wei Feng [1 ,2 ]
Yang, Yun Sheng [1 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Dept Gastroenterol & Hepatol, 28 Fuxing Rd, Beijing 100853, Peoples R China
[2] Shenzhen Univ, Div Gastroenterol & Hepatol, Hlth Sci Ctr, Shenzhen, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
diarrhea; DNA; irritable bowel syndrome; mitochondria; single nucleotide polymorphism; DNA POLYMORPHISMS; LEIGH-SYNDROME; CONTROL REGION; DISEASE; MTDNA; DISORDERS; MUTATION; ANTIDEPRESSANTS; POPULATION; LONGEVITY;
D O I
10.1111/1751-2980.12597
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
OBJECTIVESTo investigate whether single nucleotide polymorphisms (SNPs) in the mitochondrial displacement loop (D-loop) were associated with irritable bowel syndrome (IBS). METHODSAltogether 40 participants were recruited and classified into three groups, including 20 that fulfilled the Rome III criteria for diarrhea-predominant IBS (IBS-D), 10 with constipation-predominant IBS (IBS-C), and 10 healthy volunteers (controls). DNA was extracted from biopsy specimens of the colon obtained during routine colonoscopies. The mitochondrial D-loop was sequenced and variants were identified in comparison with the reference sequence from GenBank. We searched GenBank and MITOMAP to determine whether a variant could be considered an SNP. RESULTSNo significant differences in sex, age and body mass index were found among the three groups. The average numbers of SNPs in the IBS-D, IBS-C and control groups were 12.22.7, 9.8 +/- 1.8 and 9.9 +/- 2.1, respectively. The frequency of SNPs was significantly higher in the IBS-D group than in the IBS-C group and controls (P < 0.05). No significant difference was found between the latter two groups. Each SNP was compared among the three groups and the frequency of 199C was found to be significantly higher in the control group than in the IBS-D group (P =0.03), but no significant difference in its frequency was found between the IBS-C group and controls. CONCLUSIONSPatients with IBS-D have a higher incidence of SNPs in the mitochondrial D-loop than controls. The genotype 199C may be associated with a lower risk of IBS-D.
引用
收藏
页码:295 / 300
页数:6
相关论文
共 50 条
  • [21] Targeting diarrhea-predominant irritable bowel syndrome: hopes or hypes?
    Bassotti, Gabrio
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2024,
  • [22] Decreased mucosal cytokines in diarrhea-predominant irritable bowel syndrome
    Chang, L
    Anton, P
    Elliott, J
    Reinholdt, J
    Taing, P
    Mayer, E
    GASTROENTEROLOGY, 2002, 122 (04) : A552 - A552
  • [23] RIFAXIMIN IS A SAFE THERAPY FOR DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME
    Weinstock, Leonard B.
    Pimentel, Mark
    Heimanson, Zeev
    Lembo, Anthony
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2018, 33 : S331 - S332
  • [24] A Randomized, Controlled Exploratory Study of Clonidine in Diarrhea-Predominant Irritable Bowel Syndrome
    Camilleri, Michael
    Kim, Doe-Young
    Mckinzie, Sanna
    Kim, H. Jae
    Thomforde, George M.
    Burton, Duane D.
    Low, Phillip A.
    Zinsmeister, Alan R.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2003, 1 (02) : 111 - 121
  • [25] Misinterpreting Diarrhea-Predominant Irritable Bowel Syndrome and Functional Diarrhea: Pathophysiological Highlights
    Sciume, Giusi Desire
    Berti, Ginevra
    Lambiase, Christian
    Paglianiti, Italia
    Villanacci, Vincenzo
    Rettura, Francesco
    Grosso, Antonio
    Ricchiuti, Angelo
    Bortoli, Nicola de
    Usai Satta, Paolo
    Bassotti, Gabrio
    Bellini, Massimo
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (18)
  • [26] Characterization of kynurenine pathway in patients with diarrhea-predominant irritable bowel syndrome
    Li, Pingping
    Zheng, Jimin
    Bai, Yun
    Wang, Dingxin
    Cui, Zijin
    Li, Yueqin
    Zhang, Jian
    Wang, Yuzhen
    EUROPEAN JOURNAL OF HISTOCHEMISTRY, 2020, 64 : 14 - 21
  • [27] Patient-Centric Care of Diarrhea-Predominant Irritable Bowel Syndrome
    Lacy, Brian E.
    JOURNAL OF FAMILY PRACTICE, 2019, 68 (08): : S43 - S48
  • [28] Evaluation of Crofelemer in the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome Patients
    Mangel, Allen W.
    Chaturvedi, Pravin
    DIGESTION, 2008, 78 (04) : 180 - 186
  • [29] Clinical Pearls for Irritable Bowel Syndrome Management of the Diarrhea-Predominant Subtype
    Lacy, Brian E.
    O'Shana, Tracia
    GASTROENTEROLOGY NURSING, 2014, 37 (06) : 392 - 405
  • [30] Rifaximin in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome Reply
    Lembo, Anthony J.
    GASTROENTEROLOGY, 2017, 152 (06) : 1630 - +